{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:20:46Z","timestamp":1784132446647,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672856"],"award-info":[{"award-number":["81672856"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07598-6","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T11:53:30Z","timestamp":1767095610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The TP53-LGALS4 axis modulates the tumor immune microenvironment and synergizes with anti PD-L1 therapy in colorectal cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Fan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renchao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dapeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houjie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4402-5472","authenticated-orcid":false,"given":"Jianjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"7598_CR1","doi-asserted-by":"publisher","first-page":"pky073","DOI":"10.1093\/jncics\/pky073","volume":"2","author":"LH Nguyen","year":"2018","unstructured":"Nguyen LH, Liu P-H, Zheng X, Keum N, Zong X, Li X, et al. Sedentary Behaviors, TV viewing Time, and risk of Young-Onset colorectal cancer. JNCI Cancer Spectr. 2018;2:pky073. https:\/\/doi.org\/10.1093\/jncics\/pky073.","journal-title":"JNCI Cancer Spectr"},{"key":"7598_CR2","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/s41575-019-0253-4","volume":"17","author":"LJ Hofseth","year":"2020","unstructured":"Hofseth LJ, Hebert JR, Chanda A, Chen H, Love BL, Pena MM, et al. Early-onset colorectal cancer: initial clues and current views. Nat Rev Gastroenterol Hepatol. 2020;17:352\u201364. https:\/\/doi.org\/10.1038\/s41575-019-0253-4.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7598_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1053\/j.gastro.2019.07.055","volume":"158","author":"EM Stoffel","year":"2020","unstructured":"Stoffel EM, Murphy CC. Epidemiology and mechanisms of the increasing incidence of colon and rectal cancers in young adults. Gastroenterology. 2020;158:341\u201353. https:\/\/doi.org\/10.1053\/j.gastro.2019.07.055.","journal-title":"Gastroenterology"},{"key":"7598_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"7598_CR5","doi-asserted-by":"publisher","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics. CA Cancer J Clin. 2024;74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","DOI":"10.3322\/caac.21820"},{"key":"7598_CR6","doi-asserted-by":"publisher","first-page":"6009","DOI":"10.21873\/anticanres.14622","volume":"40","author":"EN Kontomanolis","year":"2020","unstructured":"Kontomanolis EN, Koutras A, Syllaios A, Schizas D, Mastoraki A, Garmpis N, et al. Role of oncogenes and Tumor-suppressor genes in carcinogenesis: A review. Anticancer Res. 2020;40:6009\u201315. https:\/\/doi.org\/10.21873\/anticanres.14622.","journal-title":"Anticancer Res"},{"key":"7598_CR7","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1159\/000495956","volume":"51","author":"L-H Wang","year":"2018","unstructured":"Wang L-H, Wu C-F, Rajasekaran N, Shin YK. Loss of tumor suppressor gene function in human cancer: an overview. Cell Physiol Biochem. 2018;51:2647\u201393. https:\/\/doi.org\/10.1159\/000495956.","journal-title":"Cell Physiol Biochem"},{"key":"7598_CR8","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X, de Reyni\u00e8s A, Schlicker A, Soneson C, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21:1350\u20136. https:\/\/doi.org\/10.1038\/nm.3967.","journal-title":"Nat Med"},{"key":"7598_CR9","doi-asserted-by":"publisher","first-page":"e36550","DOI":"10.1016\/j.heliyon.2024.e36550","volume":"10","author":"Z Su","year":"2024","unstructured":"Su Z, El Hage M, Linnebacher M. Mutation patterns in colorectal cancer and their relationship with prognosis. Heliyon. 2024;10:e36550. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36550.","journal-title":"Heliyon"},{"key":"7598_CR10","doi-asserted-by":"publisher","first-page":"188556","DOI":"10.1016\/j.bbcan.2021.188556","volume":"1876","author":"LJ Hern\u00e1ndez Borrero","year":"2021","unstructured":"Hern\u00e1ndez Borrero LJ, El-Deiry WS. Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting. Biochim Biophys Acta Rev Cancer. 2021;1876:188556. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188556.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"7598_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41588-024-02039-4","volume":"57","author":"JS Funk","year":"2025","unstructured":"Funk JS, Klimovich M, Drangenstein D, Pielhoop O, Hunold P, Borowek A, et al. Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations. Nat Genet. 2025;57:140\u201353. https:\/\/doi.org\/10.1038\/s41588-024-02039-4.","journal-title":"Nat Genet"},{"key":"7598_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41573-022-00571-8","volume":"22","author":"O Hassin","year":"2023","unstructured":"Hassin O, Oren M. Drugging p53 in cancer: one protein, many targets. Nat Rev Drug Discov. 2023;22:127\u201344. https:\/\/doi.org\/10.1038\/s41573-022-00571-8.","journal-title":"Nat Rev Drug Discov"},{"key":"7598_CR13","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/sj.cdd.4400535","volume":"6","author":"GA Rabinovich","year":"1999","unstructured":"Rabinovich GA. Galectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy. Cell Death Differ. 1999;6:711\u201321. https:\/\/doi.org\/10.1038\/sj.cdd.4400535.","journal-title":"Cell Death Differ"},{"key":"7598_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/s0304-4165(02)00310-0","volume":"1572","author":"DNW Cooper","year":"2002","unstructured":"Cooper DNW. Galectinomics: finding themes in complexity. Biochim Biophys Acta. 2002;1572:209\u201331. https:\/\/doi.org\/10.1016\/s0304-4165(02)00310-0.","journal-title":"Biochim Biophys Acta"},{"key":"7598_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/s0304-4165(02)00315-x","volume":"1572","author":"A Danguy","year":"2002","unstructured":"Danguy A, Camby I, Kiss R. Galectins and cancer. Biochim Biophys Acta. 2002;1572:285\u201393. https:\/\/doi.org\/10.1016\/s0304-4165(02)00315-x.","journal-title":"Biochim Biophys Acta"},{"key":"7598_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1159\/000084545","volume":"136","author":"F-T Liu","year":"2005","unstructured":"Liu F-T. Regulatory roles of galectins in the immune response. Int Arch Allergy Immunol. 2005;136:385\u2013400. https:\/\/doi.org\/10.1159\/000084545.","journal-title":"Int Arch Allergy Immunol"},{"key":"7598_CR17","doi-asserted-by":"publisher","first-page":"1462061","DOI":"10.3389\/fphar.2024.1462061","volume":"15","author":"Z Cao","year":"2024","unstructured":"Cao Z, Leng P, Xu H, Li X. The regulating role of galectin-9 in immune cell populations. Front Pharmacol. 2024;15:1462061. https:\/\/doi.org\/10.3389\/fphar.2024.1462061.","journal-title":"Front Pharmacol"},{"key":"7598_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bbcan.2015.03.003","volume":"1855","author":"VL Thijssen","year":"2015","unstructured":"Thijssen VL, Heusschen R, Caers J, Griffioen AW. Galectin expression in cancer diagnosis and prognosis: A systematic review. Biochim Biophys Acta. 2015;1855:235\u201347. https:\/\/doi.org\/10.1016\/j.bbcan.2015.03.003.","journal-title":"Biochim Biophys Acta"},{"key":"7598_CR19","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/ijms19020430","volume":"19","author":"F-C Chou","year":"2018","unstructured":"Chou F-C, Chen H-Y, Kuo C-C, Sytwu H-K. Role of galectins in tumors and in clinical immunotherapy. Int J Mol Sci. 2018;19:430. https:\/\/doi.org\/10.3390\/ijms19020430.","journal-title":"Int J Mol Sci"},{"key":"7598_CR20","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/s41590-023-01634-7","volume":"24","author":"J Li","year":"2023","unstructured":"Li J, Liu X-G, Ge R-L, Yin Y-P, Liu Y, Lu W-P, et al. The ligation between ERMAP, galectin-9 and dectin-2 promotes Kupffer cell phagocytosis and antitumor immunity. Nat Immunol. 2023;24:1813\u201324. https:\/\/doi.org\/10.1038\/s41590-023-01634-7.","journal-title":"Nat Immunol"},{"key":"7598_CR21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41590-020-00844-7","volume":"22","author":"AJ Russo","year":"2021","unstructured":"Russo AJ, Vasudevan SO, M\u00e9ndez-Huergo SP, Kumari P, Menoret A, Duduskar S, et al. Intracellular immune sensing promotes inflammation via gasdermin D-driven release of a lectin alarmin. Nat Immunol. 2021;22:154\u201365. https:\/\/doi.org\/10.1038\/s41590-020-00844-7.","journal-title":"Nat Immunol"},{"key":"7598_CR22","doi-asserted-by":"publisher","first-page":"e0152599","DOI":"10.1371\/journal.pone.0152599","volume":"11","author":"Y Wang","year":"2016","unstructured":"Wang Y, Sun J, Ma C, Gao W, Song B, Xue H, et al. Reduced expression of Galectin-9 contributes to a poor outcome in colon cancer by inhibiting NK cell chemotaxis partially through the Rho\/ROCK1 signaling pathway. PLoS ONE. 2016;11:e0152599. https:\/\/doi.org\/10.1371\/journal.pone.0152599.","journal-title":"PLoS ONE"},{"key":"7598_CR23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3389\/fphys.2018.00452","volume":"9","author":"X Zhou","year":"2018","unstructured":"Zhou X, Sun L, Jing D, Xu G, Zhang J, Lin L, et al. Galectin-9 expression predicts favorable clinical outcome in solid tumors: A systematic review and Meta-Analysis. Front Physiol. 2018;9:452. https:\/\/doi.org\/10.3389\/fphys.2018.00452.","journal-title":"Front Physiol"},{"key":"7598_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s43556-025-00267-6","volume":"6","author":"Z Yan","year":"2025","unstructured":"Yan Z, Wang C, Wu J, Wang J, Ma T. TIM-3 teams up with PD-1 in cancer immunotherapy: mechanisms and perspectives. Mol Biomed. 2025;6:27. https:\/\/doi.org\/10.1186\/s43556-025-00267-6.","journal-title":"Mol Biomed"},{"key":"7598_CR25","doi-asserted-by":"publisher","first-page":"6414","DOI":"10.3390\/ijms23126414","volume":"23","author":"M Michalak","year":"2022","unstructured":"Michalak M, Golde V, Helm D, Kaltner H, Gebert J, Kopitz J. Combining Recombinase-Mediated cassette exchange strategy with quantitative proteomic and phosphoproteomic analyses to inspect intracellular functions of the tumor suppressor Galectin-4 in colorectal cancer cells. Int J Mol Sci. 2022;23:6414. https:\/\/doi.org\/10.3390\/ijms23126414.","journal-title":"Int J Mol Sci"},{"key":"7598_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1158\/2326-6066.CIR-21-1088","volume":"11","author":"T Lidstr\u00f6m","year":"2023","unstructured":"Lidstr\u00f6m T, Cumming J, Gaur R, Fr\u00e4ngsmyr L, Pateras IS, Mickert MJ, et al. Extracellular galectin 4 drives immune evasion and promotes T-cell apoptosis in pancreatic cancer. Cancer Immunol Res. 2023;11:72\u201392. https:\/\/doi.org\/10.1158\/2326-6066.CIR-21-1088.","journal-title":"Cancer Immunol Res"},{"key":"7598_CR27","doi-asserted-by":"publisher","first-page":"1453630","DOI":"10.3389\/fcell.2024.1453630","volume":"12","author":"K Ji","year":"2024","unstructured":"Ji K, Jia H, Liu Z, Yu G, Wen R, Zhang T, et al. New insight in immunotherapy and combine therapy in colorectal cancer. Front Cell Dev Biol. 2024;12:1453630. https:\/\/doi.org\/10.3389\/fcell.2024.1453630.","journal-title":"Front Cell Dev Biol"},{"key":"7598_CR28","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1007\/s00262-023-03441-3","volume":"72","author":"Y Mao","year":"2023","unstructured":"Mao Y, Xie H, Lv M, Yang Q, Shuang Z, Gao F, et al. The landscape of objective response rate of anti-PD-1\/L1 monotherapy across 31 types of cancer: a system review and novel biomarker investigating. Cancer Immunol Immunother. 2023;72:2483\u201398. https:\/\/doi.org\/10.1007\/s00262-023-03441-3.","journal-title":"Cancer Immunol Immunother"},{"key":"7598_CR29","doi-asserted-by":"publisher","first-page":"e70030","DOI":"10.1002\/mog2.70030","volume":"4","author":"H Sun","year":"2025","unstructured":"Sun H, Huang D, Zhang H, Dong M, Wang S, Sun M, et al. Targeting immune checkpoints: basic signaling pathways and clinical translation in cancer therapeutics. MedComm \u2013 Oncol. 2025;4:e70030. https:\/\/doi.org\/10.1002\/mog2.70030.","journal-title":"MedComm \u2013 Oncol"},{"key":"7598_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1200\/JCO.19.02107","volume":"38","author":"DT Le","year":"2020","unstructured":"Le DT, Kim TW, Van Cutsem E, Geva R, J\u00e4ger D, Hara H, et al. Phase II Open-Label study of pembrolizumab in Treatment-Refractory, microsatellite Instability-High\/Mismatch Repair-Deficient metastatic colorectal cancer: KEYNOTE-164. J Clin Oncol. 2020;38:11\u20139. https:\/\/doi.org\/10.1200\/JCO.19.02107.","journal-title":"J Clin Oncol"},{"key":"7598_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejca.2023.02.016","volume":"186","author":"DT Le","year":"2023","unstructured":"Le DT, Diaz LA, Kim TW, Van Cutsem E, Geva R, J\u00e4ger D, et al. Pembrolizumab for previously treated, microsatellite instability-high\/mismatch repair-deficient advanced colorectal cancer: final analysis of KEYNOTE-164. Eur J Cancer. 2023;186:185\u201395. https:\/\/doi.org\/10.1016\/j.ejca.2023.02.016.","journal-title":"Eur J Cancer"},{"key":"7598_CR32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1200\/JCO.21.01015","volume":"40","author":"H-J Lenz","year":"2022","unstructured":"Lenz H-J, Van Cutsem E, Luisa Limon M, Wong KYM, Hendlisz A, Aglietta M, et al. First-Line nivolumab plus Low-Dose ipilimumab for microsatellite Instability-High\/Mismatch Repair-Deficient metastatic colorectal cancer: the phase II checkmate 142 study. J Clin Oncol. 2022;40:161\u201370. https:\/\/doi.org\/10.1200\/JCO.21.01015.","journal-title":"J Clin Oncol"},{"key":"7598_CR33","doi-asserted-by":"publisher","unstructured":"Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010;138:2073\u20132087.e3 https:\/\/doi.org\/10.1053\/j.gastro.2009.12.064.","DOI":"10.1053\/j.gastro.2009.12.064"},{"key":"7598_CR34","doi-asserted-by":"publisher","first-page":"188447","DOI":"10.1016\/j.bbcan.2020.188447","volume":"1874","author":"DY Lizardo","year":"2020","unstructured":"Lizardo DY, Kuang C, Hao S, Yu J, Huang Y, Zhang L. Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: from bench to bedside. Biochim Biophys Acta Rev Cancer. 2020;1874:188447. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188447.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"7598_CR35","doi-asserted-by":"publisher","first-page":"eado8758","DOI":"10.1126\/sciimmunol.ado8758","volume":"9","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zhang Y, Li M, Ming T, Zhang C, Huang C, et al. Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated DsRNA accumulation and viral mimicry. Sci Immunol. 2024;9:eado8758. https:\/\/doi.org\/10.1126\/sciimmunol.ado8758.","journal-title":"Sci Immunol"},{"key":"7598_CR36","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/s43018-021-00269-7","volume":"2","author":"AR Parikh","year":"2021","unstructured":"Parikh AR, Szabolcs A, Allen JN, Clark JW, Wo JY, Raabe M, et al. Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial. Nat Cancer. 2021;2:1124\u201335. https:\/\/doi.org\/10.1038\/s43018-021-00269-7.","journal-title":"Nat Cancer"},{"key":"7598_CR37","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/s41564-024-01695-w","volume":"9","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wong CC, Ding Y, Gao M, Wen J, Lau HC-H, et al. Peptostreptococcus anaerobius mediates anti-PD1 therapy resistance and exacerbates colorectal cancer via myeloid-derived suppressor cells in mice. Nat Microbiol. 2024;9:1467\u201382. https:\/\/doi.org\/10.1038\/s41564-024-01695-w.","journal-title":"Nat Microbiol"},{"key":"7598_CR38","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang S, Li H, Zhang L, Mu W, Zhang Y, Chen T, et al. Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res. 2025;53:D1670\u20136. https:\/\/doi.org\/10.1093\/nar\/gkae973.","journal-title":"Nucleic Acids Res"},{"key":"7598_CR39","doi-asserted-by":"publisher","first-page":"W420","DOI":"10.1093\/nar\/gkac373","volume":"50","author":"Y Xie","year":"2022","unstructured":"Xie Y, Li H, Luo X, Li H, Gao Q, Zhang L, et al. IBS 2.0: an upgraded illustrator for the visualization of biological sequences. Nucleic Acids Res. 2022;50:W420\u20136. https:\/\/doi.org\/10.1093\/nar\/gkac373.","journal-title":"Nucleic Acids Res"},{"key":"7598_CR40","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41577-022-00829-7","volume":"23","author":"F-T Liu","year":"2023","unstructured":"Liu F-T, Stowell SR. The role of galectins in immunity and infection. Nat Rev Immunol. 2023;23:479\u201394. https:\/\/doi.org\/10.1038\/s41577-022-00829-7.","journal-title":"Nat Rev Immunol"},{"key":"7598_CR41","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1053\/j.gastro.2024.03.007","volume":"167","author":"D Yang","year":"2024","unstructured":"Yang D, Sun X, Moniruzzaman R, Wang H, Citu C, Zhao Z, et al. Genetic deletion of Galectin-3 inhibits pancreatic cancer progression and enhances the efficacy of immunotherapy. Gastroenterology. 2024;167:298\u2013314. https:\/\/doi.org\/10.1053\/j.gastro.2024.03.007.","journal-title":"Gastroenterology"},{"key":"7598_CR42","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1002\/med.22041","volume":"44","author":"E Puri\u0107","year":"2024","unstructured":"Puri\u0107 E, Nilsson UJ, Anderluh M. Galectin-8 Inhibition and functions in immune response and tumor biology. Med Res Rev. 2024;44:2236\u201365. https:\/\/doi.org\/10.1002\/med.22041.","journal-title":"Med Res Rev"},{"key":"7598_CR43","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41467-021-21099-2","volume":"12","author":"R Yang","year":"2021","unstructured":"Yang R, Sun L, Li C-F, Wang Y-H, Yao J, Li H, et al. Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy. Nat Commun. 2021;12:832. https:\/\/doi.org\/10.1038\/s41467-021-21099-2.","journal-title":"Nat Commun"},{"key":"7598_CR44","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499:214\u20138. https:\/\/doi.org\/10.1038\/nature12213.","journal-title":"Nature"},{"key":"7598_CR45","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.cell.2024.04.002","volume":"187","author":"Z Zong","year":"2024","unstructured":"Zong Z, Xie F, Wang S, Wu X, Zhang Z, Yang B, et al. Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis. Cell. 2024;187:2375\u2013e239233. https:\/\/doi.org\/10.1016\/j.cell.2024.04.002.","journal-title":"Cell"},{"key":"7598_CR46","doi-asserted-by":"publisher","first-page":"e159839","DOI":"10.1172\/JCI159839","volume":"132","author":"EE Wicks","year":"2022","unstructured":"Wicks EE, Semenza GL. Hypoxia-inducible factors: cancer progression and clinical translation. J Clin Invest. 2022;132:e159839. https:\/\/doi.org\/10.1172\/JCI159839.","journal-title":"J Clin Invest"},{"key":"7598_CR47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cytogfr.2022.11.001","volume":"68","author":"L Ye","year":"2022","unstructured":"Ye L, Jiang Y, Zhang M. Crosstalk between glucose metabolism, lactate production and immune response modulation. Cytokine Growth Factor Rev. 2022;68:81\u201392. https:\/\/doi.org\/10.1016\/j.cytogfr.2022.11.001.","journal-title":"Cytokine Growth Factor Rev"},{"key":"7598_CR48","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","volume":"8","author":"H Wang","year":"2023","unstructured":"Wang H, Guo M, Wei H, Chen Y. Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduct Target Ther. 2023;8:92. https:\/\/doi.org\/10.1038\/s41392-023-01347-1.","journal-title":"Signal Transduct Target Ther"},{"key":"7598_CR49","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","volume":"10","author":"J Chen","year":"2025","unstructured":"Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y, et al. Lactate and lactylation in cancer. Signal Transduct Target Ther. 2025;10:38. https:\/\/doi.org\/10.1038\/s41392-024-02082-x.","journal-title":"Signal Transduct Target Ther"},{"key":"7598_CR50","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41573-023-00636-2","volume":"22","author":"KV Mari\u00f1o","year":"2023","unstructured":"Mari\u00f1o KV, Cagnoni AJ, Croci DO, Rabinovich GA. Targeting galectin-driven regulatory circuits in cancer and fibrosis. Nat Rev Drug Discov. 2023;22:295\u2013316. https:\/\/doi.org\/10.1038\/s41573-023-00636-2.","journal-title":"Nat Rev Drug Discov"},{"key":"7598_CR51","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ccell.2022.05.004","volume":"40","author":"K Kersten","year":"2022","unstructured":"Kersten K, Hu KH, Combes AJ, Samad B, Harwin T, Ray A, et al. Spatiotemporal co-dependency between macrophages and exhausted CD8\u2009+\u2009T cells in cancer. Cancer Cell. 2022;40:624\u2013e6389. https:\/\/doi.org\/10.1016\/j.ccell.2022.05.004.","journal-title":"Cancer Cell"},{"key":"7598_CR52","doi-asserted-by":"publisher","first-page":"540","DOI":"10.2741\/3261","volume":"14","author":"R Bonecchi","year":"2009","unstructured":"Bonecchi R, Galliera E, Borroni EM, Corsi MM, Locati M, Mantovani A. Chemokines and chemokine receptors: an overview. Front Biosci (Landmark Ed). 2009;14:540\u201351. https:\/\/doi.org\/10.2741\/3261.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"7598_CR53","doi-asserted-by":"publisher","first-page":"djv406","DOI":"10.1093\/jnci\/djv406","volume":"108","author":"AE Vilgelm","year":"2015","unstructured":"Vilgelm AE, Johnson CA, Prasad N, Yang J, Chen S-C, Ayers GD, et al. Connecting the dots: Therapy-Induced senescence and a Tumor-Suppressive immune microenvironment. J Natl Cancer Inst. 2015;108:djv406. https:\/\/doi.org\/10.1093\/jnci\/djv406.","journal-title":"J Natl Cancer Inst"},{"key":"7598_CR54","doi-asserted-by":"publisher","first-page":"eaay1357","DOI":"10.1126\/sciadv.aay1357","volume":"5","author":"J-M Williford","year":"2019","unstructured":"Williford J-M, Ishihara J, Ishihara A, Mansurov A, Hosseinchi P, Marchell TM, et al. Recruitment of CD103\u2009+\u2009dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy. Sci Adv. 2019;5:eaay1357. https:\/\/doi.org\/10.1126\/sciadv.aay1357.","journal-title":"Sci Adv"},{"key":"7598_CR55","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-017-0541-9","volume":"10","author":"B Liu","year":"2017","unstructured":"Liu B, Song Y, Liu D. Recent development in clinical applications of PD-1 and PD-L1 antibodies for cancer immunotherapy. J Hematol Oncol. 2017;10:174. https:\/\/doi.org\/10.1186\/s13045-017-0541-9.","journal-title":"J Hematol Oncol"},{"key":"7598_CR56","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1038\/d41586-017-08699-z","volume":"552","author":"E Bender","year":"2017","unstructured":"Bender E. Cancer immunotherapy. Nature. 2017;552:S61. https:\/\/doi.org\/10.1038\/d41586-017-08699-z.","journal-title":"Nature"},{"key":"7598_CR57","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1615\/ForumImmunDisTher.2015014188","volume":"6","author":"J Lee","year":"2015","unstructured":"Lee J, Ahn E, Kissick HT, Ahmed R, Reinvigorating Exhausted T. Cells by Blockade of the PD-1 pathway. Immunopathol Dis Th. 2015;6:7\u201317. https:\/\/doi.org\/10.1615\/ForumImmunDisTher.2015014188.","journal-title":"Immunopathol Dis Th"},{"key":"7598_CR58","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"SR Gordon","year":"2017","unstructured":"Gordon SR, Maute RL, Dulken BW, Hutter G, George BM, McCracken MN, et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature. 2017;545:495\u20139. https:\/\/doi.org\/10.1038\/nature22396.","journal-title":"Nature"},{"key":"7598_CR59","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41591-018-0085-8","volume":"24","author":"KC Barry","year":"2018","unstructured":"Barry KC, Hsu J, Broz ML, Cueto FJ, Binnewies M, Combes AJ, et al. A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments. Nat Med. 2018;24:1178\u201391. https:\/\/doi.org\/10.1038\/s41591-018-0085-8.","journal-title":"Nat Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07598-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07598-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07598-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:49:43Z","timestamp":1770979783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07598-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7598"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07598-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mice: The Animal Care and Use Committee of Army Medical University (AMU) reviewed and approved the protocol for the use of the animals in this study. Human specimens: The use of clinical specimens was approved by the Bishan Hospital Ethics Committee. Written informed consent was obtained from all the patients. No: cqbykyll-20250110-36.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"225"}}